Molkentine, Jessica M.
Fujimoto, Tara N.
Horvath, Thomas D. http://orcid.org/0000-0001-9761-3484
Grossberg, Aaron J. http://orcid.org/0000-0003-4690-4948
Garcia, Carolina J. Garcia
Deorukhkar, Amit
de la Cruz Bonilla, Marimar
Lin, Daniel
Samuel, Errol L. G.
Chan, Wai Kin
Lorenzi, Philip L. http://orcid.org/0000-0003-0385-7774
Piwnica-Worms, Helen
Dantzer, Robert
Tour, James M. http://orcid.org/0000-0002-8479-9328
Mason, Kathryn A.
Taniguchi, Cullen M. http://orcid.org/0000-0002-8052-3316
Article History
Received: 25 April 2018
Accepted: 30 November 2018
First Online: 13 February 2019
Competing Interests
: Intellectual property on the use of WR-2721 to protect the GI tract during radiation therapy is owned by three universities: (Rice Tech ID 2013-054; Stanford Ref. No. S13-103; MDACC Ref. No. MDA13-07; Ref. No. 58001-P001V4). That intellectual property is in the process of being licensed or has been licensed to a company in which C.M.T., K.A.M., and J.M.T. are shareholders but not officers or directors. For J.M.T. all conflicts are managed by regular disclosure to the Rice University Office of Sponsored Programs and Research Compliance. The remaining authors disclose no competing interests. C.M.T. is also a member of the Clinical Advisory Board of Cyberknife (Accuray, Sunnyvale, CA).